Literature DB >> 27830390

Harvest of at Least 23 Lymph Nodes is Indispensable for Stage N3 Gastric Cancer Patients.

Gaozan Zheng1, Fan Feng2, Man Guo1, Guanghui Xu1, Shushang Liu1, Zhen Liu1, Li Sun1, Liu Hong1, Jianjun Yang1, Xiao Lian1, Daiming Fan1, Hongwei Zhang3.   

Abstract

BACKGROUND: The National Comprehensive Cancer Network (NCCN) recommends that at least 15 lymph nodes (LNs) be removed during radical gastrectomy. This study aims to investigate the optimal number of LNs resected for radical gastrectomy. PATIENTS AND METHODS: From September 2008 to March 2015, a total of 1990 gastric cancer patients were enrolled in this study. Clinicopathological features and survivals were recorded, and the association between the number of LNs resected and the prognosis of gastric cancer were analyzed.
RESULTS: Overall, 1520 males (76.4%) and 470 females (23.6%) were included in the study, with a median age of 57 years (range 20-90). The median number of LNs resected was 24 (range 15-83) for stage N1, 25 (range 15-62) for stage N2, 25 (range 15-88) for stage N3a, and 28 (range 16-73) for stage N3b. The optimal cut-off value for the number of LNs resected was 22 for stage N3a (p = 0.000) and N3b (p = 0.003) patients, while no other cut-off value was significantly superior to 15 for stage N1-2 patients (both p > 0.05). Age, tumor size, tumor depth, and number of LNs resected were independent prognostic predictors for stage N3a patients, while resection type and number of LNs resected were independent prognostic predictors for stage N3b patients. Removing more than 22 LNs exhibited a significant survival benefit compared with removing 15-22 LNs for stage N3a and N3b patients (29.7 vs. 21.6%, p = 0.000; 12.9% vs. 0%, p = 0.003, respectively).
CONCLUSION: Removing at least 23 LNs could yield better survival outcomes in stage N3 gastric cancer patients.

Entities:  

Mesh:

Year:  2016        PMID: 27830390     DOI: 10.1245/s10434-016-5667-4

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  9 in total

1.  Lymphadenectomy with Optimum of 29 Lymph Nodes Retrieved Associated with Improved Survival in Advanced Gastric Cancer: A 25,000-Patient International Database Study.

Authors:  Yanghee Woo; Bryan Goldner; Philip Ituarte; Byrne Lee; Laleh Melstrom; Taeil Son; Sung Hoon Noh; Yuman Fong; Woo Jin Hyung
Journal:  J Am Coll Surg       Date:  2016-12-23       Impact factor: 6.113

2.  Impact of Laparoscopic Converted to Open Gastrectomy on Short- and Long-Term Outcomes of Patients with Locally Advanced Gastric Cancer: A Propensity Score-Matched Analysis.

Authors:  Feng-Ni Xie; Jie Chen; Zheng-Yan Li; Bin Bai; Dan Song; Shuai Xu; Xiao-Tian Song; Gang Ji
Journal:  J Gastrointest Surg       Date:  2021-04-05       Impact factor: 3.452

3.  Surgeon-Pathologist Team Approach Dramatically Affects Lymph Nodes Detection and Improves Patients' Short-Term Outcome.

Authors:  Maria Raffaella Ambrosio; Bruno Perotti; Alda Battini; Caterina Fattorini; Andrea Cavazzana; Rocco Pasqua; Piergaspare Palumbo; Liano Gia; Marco Arganini
Journal:  Cancers (Basel)       Date:  2022-02-18       Impact factor: 6.639

4.  Incidence and risk factors of postoperative complications after robotic gastrectomy for gastric cancer: an analysis of 817 cases based on 10-year experience in a large-scale center.

Authors:  Zheng-Yan Li; Yong-Liang Zhao; Feng Qian; Bo Tang; Jun Chen; Fan Zhang; Ping-Ang Li; Zi-Yan Luo; Yan Shi; Pei-Wu Yu
Journal:  Surg Endosc       Date:  2021-01-25       Impact factor: 4.584

5.  External Validation of a Nomogram Developed for Predicting Overall Survival in Gastric Cancer Patients with Insufficient Number of Examined Lymph Nodes.

Authors:  Mehmet Kubat; Mustafa Omer Yazicioglu; Bahadir Osman Bozkirli; Riza Haldun Gundogdu
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2022-03-28

6.  Validation of the American Joint Commission on Cancer (8th edition) changes for patients with stage III gastric cancer: survival analysis of a large series from a Specialized Eastern Center.

Authors:  Jun Lu; Chao-Hui Zheng; Long-Long Cao; Shao-Wei Ling; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Qi-Yue Chen; Mi Lin; Ru-Hong Tu; Chang-Ming Huang
Journal:  Cancer Med       Date:  2017-09-14       Impact factor: 4.452

7.  Retrieved lymph nodes from different anatomic groups in gastric cancer: a proposed optimal number, comparison with other nodal classification strategies and its impact on prognosis.

Authors:  Siwei Pan; Pengliang Wang; Yanan Xing; Kai Li; Zhenning Wang; Huimian Xu; Zhi Zhu
Journal:  Cancer Commun (Lond)       Date:  2019-09-13

8.  Application of clockwise modularized laparoscopic lymphadenectomy in the suprapancreatic area, a propensity score matching study and comparison with open gastrectomy.

Authors:  Hua Yang; Wei-Han Zhang; Kai Liu; Yu-Qing Dan; Xin-Zu Chen; Kun Yang; Zhi-Xin Chen; Jia-Ping Chen; Zong-Guang Zhou; Jian-Kun Hu
Journal:  Surg Endosc       Date:  2020-10-08       Impact factor: 4.584

9.  Surgical and oncological outcomes of robotic- versus laparoscopic-assisted distal gastrectomy with D2 lymphadenectomy for advanced gastric cancer: a propensity score‑matched analysis of 1164 patients.

Authors:  Gengmei Gao; Hualin Liao; Qunguang Jiang; Dongning Liu; Taiyuan Li
Journal:  World J Surg Oncol       Date:  2022-09-28       Impact factor: 3.253

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.